总览
机会
行情数据
数据概览
市场情绪
5
BTC 市值
山寨币季节指数
恐慌&贪婪指数
历史波动率
Ahr999 囤币指标
资金动向
3
资金流向
大单成交
大额挂单
合约分析
6
清算地图
爆仓数据
合约持仓
多空比
资金费率
费率套利
链上数据
1
大额转账
技术指标
3
RSI 热力图
MACD 概览
普尔倍数
机构数据
2
ETF 数据
投融资
投融资
Tharimmune
Biotechnology company(THAR)
暂无数据
分享
同类项目
*不可点击时,表示无详情数据展示
Forward Industries
A public company holding and actively managing Solana reserves
Fold
A finance app that earns bitcoin on daily spending
H100 Group
Health technology and investment consulting(NGM:H100)
SharpLink Gaming
Gaming Affiliate Marketing Platform(NASDAQ:SBET)
Quantum Solutions
AI technology listed company(TSE: 2338.T)
AI Financial
Payment infrastructure company (NASDAQ:AIFC)
Tron Inc
Design and development company(Nasdaq:TRON)
Neptune Digital Assets
Blockchain company(CVE: NDA)
关于 Tharimmune
Tharimmune, Inc. (THAR) is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology.
社区
Website
标签
Digital Asset Treasury
Publicly listed company
Crypto Stocks
Website
Digital Asset Treasury
Publicly listed company
Crypto Stocks
热度值变化趋势
24H
1W
1M
全部
24H
1W
1M
全部
暂无数据
团队成员
Mark Wendland
Chairman and CEO
Angela Dominy Radkowski
COO
投资方
Liberty City Ventures
DRW Venture Capital
Kraken
Polychain
ARK Invest
投融资详情
Post-IPO
(
2025-11-03
)
金额:
$5.40 亿
投资方:
Liberty City Ventures
DRW Venture Capital
Kraken
Polychain
ARK Invest
估值:
--